Skip to main content
SpringerLink
Log in

Recent advances and controversies in the management of Wilms’ tumor

  • Chapter
Book cover Urologic Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 46))

  • 58 Accesses

Abstract

Over the past 30 years, there has been significant improvement in the survival of patients with Wilms’ tumor. Cure rates have improved due to the multitherapeutic approach to the management of the tumors. Combined surgical extirpation and chemotherapy now allow for greater than 90% survival in patients with stage I disease [1]. Chemotherapy, radiation, and second-look surgical procedures can be successfully used in patients presenting with metastatic disease or extensive local disease involving adjacent organs or bilateral renal involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D’Angio GJ, Breslow N, Beckwith B, Evans A, Baum E, deLorimier A, Fernbach D, Hrabovsky E, Jones B, Kelalis P, Otherson HB, Tefft M, Thomas PRM: The treatment of Wilms’ tumor: Results of the Third National Wilms’ Tumor Study. Cancer, in press.

    Google Scholar 

  2. Breslow NE, Palmer NF, Hill LR, Buring J, D’Angio GJ Wilms’ tumor: Prognostic factors for patients without metastases at diagnosis; Results of the National Wilms’ Tumor Study. Cancer 41: 1577, 1978.

    Article  PubMed  Google Scholar 

  3. D’Angio GJ, Evans AE, Breslow N, Beckwith B, Bishop H, Feigl P, Goodwin W Leape LL, Sinks LF, Sutow W, Tefft M, Wolff J: The treatment of Wilms’ tumor: Results of the National Wilms’ Tumor Study. Cancer 38: 633, 1976.

    Article  PubMed  Google Scholar 

  4. D’Angio GJ, Evans AE, Breslow N, Beckwith B, Bishop H, Farewell V, Goodwin W, Leape L, Palmer N, Sinks L, Sutow W, Tefft M, Wolff J: The treatment of Wilms’ tumor: Results of the Second National Wilms’ Tumor Study. Cancer 47: 2302, 1981.

    Article  PubMed  Google Scholar 

  5. Breslow N, Chruchill G, Beckwith JB, Fernbach DJ, Otherson HB, Tefft M, D’Angio GJ: Prognosis for Wilms’ tumor patients with nonmetastatic disease at diagnosis: Results of the Second National Wilms’ Tumor Study. J Clin Oncol 3: 521, 1985.

    PubMed  CAS  Google Scholar 

  6. National Wilms’ Tumor Study-4 Therapeutic Trial protocol. November, 1987.

    Google Scholar 

  7. Beckwith JB: Wilms’ tumor and other renal tumors of childhood. Hum Pathol 14: 481, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Beckwith JB, Palmer NF: Histopathology and prognosis of Wilms’ tumor. Cancer 41: 1937, 1978.

    Article  PubMed  CAS  Google Scholar 

  9. Weeks DA, Beckwith JB, Mierau GA: Rhabdoid tumor of kidney: The National Wilms’ Tumor Study Experience. Lab Invest 58: 101A, 1988.

    Google Scholar 

  10. Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M: Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumours: An ultrastructural and immunohistoche-mical study. Hum Path 16: 1235, 1985.

    Article  PubMed  CAS  Google Scholar 

  11. Rousseau-Merck MF, Nogues C, Nezelof C, Marin-Cudraz B, Paulin D: Infantile renal tumors associated with hypercalcemia. Characterization of intermediate-filament clusters. Arch Patho Lab Med 107: 311, 1983.

    CAS  Google Scholar 

  12. Mayes LC, Kasselberg AG Roloff JS, Lukens JN: Hypercalcemia associated with immu-noreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (rhabdoid Wilms’ tumor). Cancer 54: 882, 1984.

    Article  PubMed  Google Scholar 

  13. Bonnin JM, Rubinstein LJ, Palmer NF Beckwith JB: The association of embryonal tumors originating in the kidney and in the brain: A report of seven cases. Cancer 54: 2137, 1984.

    Article  PubMed  Google Scholar 

  14. Beckwith JB: Wilms’ tumor and other renal tumors of childhood: An update. J Urol 136: 320, 1986.

    PubMed  CAS  Google Scholar 

  15. Pysher TJ, Beckwith JB: Clear cell sarcoma of the kidney (CCSK): Analysis of 82 cases from the Second and Third National Wilms’ Tumor Studies. Lab Invest 58: 73A, 1988.

    Google Scholar 

  16. Farewell VT, D’Angio GJ, Breslow N, Norkook P: Retrospective validation of a new staging system for Wilms’ tumor. Cancer Clin Trials 4: 167, 1981.

    PubMed  CAS  Google Scholar 

  17. Carli M, Pastore G, Paolucci G, et al.: High single doses versus 5 day divided doses of dactinomycin (AMD) in childhood rhabdomyosarcoma. Preliminary results. [Abstract] Proc ASCO 2: 76, 1983.

    Google Scholar 

  18. Blatt J, Trigg ME, Pizzo PA, et al.: Tolerance to single-dose dactinomycin in combination chemotherapy for solid tumors. Cancer Treat Rep 65: 145, 1981.

    PubMed  CAS  Google Scholar 

  19. Green DM, Finklestein JZ, Norkook P, D’Angio GJ: Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine: A report of the National Wilms’ Tumor Study. Cancer 62: 270, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Snyder HM, D’Angio GJ, Evans AE, Raney RB: Pediatric oncology. In: Campbell’s Urology, 5th ed., PC Walsh, RF Gittes, AD Perlmutter, TA Stamey (eds). WB Saunders, Philadelphia, 1986.

    Google Scholar 

  21. Reiman T, Siegel MJ, Shackelford GD: Wilms’ tumor in children: Abdominal CT and US evaluation. Radiology 160: 501, 1986.

    PubMed  CAS  Google Scholar 

  22. Clayman RV, Sheldon CA, Gonzalez R: Wilms’ tumor: An approach to vena cavai intrusion. Prog Ped Surg 15: 285, 1982.

    CAS  Google Scholar 

  23. Nakayama DK, deLorimier AA, O’Neil JA, Norkool P, D’Angio GJ: Intracardiac extension of Wilms’ tumor: A report of the National Wilms’ Tumor Study. Ann Surg 204: 693, 1986.

    Article  PubMed  CAS  Google Scholar 

  24. Wilimas JA, Douglass EC, Magel HL, Fitch S, Hustu HO: Significance of pulmonary computed tomography at diagnosis in Wilms’ tumor. J Clin Oncol 6: 1144, 1988.

    PubMed  CAS  Google Scholar 

  25. Pagano F, Pennelli N: Ureteral and vesical metastases in nephroblastoma. Br J Urol 46: 409, 1974.

    Article  PubMed  CAS  Google Scholar 

  26. Taykurt A: Wilms’ tumor at lower end of the ureter extending to the bladder: Case report. J Urol 107: 142, 1972.

    PubMed  CAS  Google Scholar 

  27. Cremin BJ: Non-function in nephroblastoma (Wilms’ tumor): A report on the excretory urography of nine cases. Clin Rad 30: 197, 1979.

    Article  CAS  Google Scholar 

  28. Canty TG, Nagaraj HS, Shearer LS: Nonvisualization of the intravenous pyelogram — a poor prognostic sign in Wilms’ tumor? J Ped Surg 14: 825, 1979.

    Article  CAS  Google Scholar 

  29. Stevens PS, Eckstein HB: Ureteral metastasis from Wilms’ tumor. J Urol 115: 467, 1976.

    PubMed  CAS  Google Scholar 

  30. Waggert J, Koop CE: Wilms’ tumor: Preoperative radiotherapy and chemotherapy in the management of massive tumors. Cancer 26: 338, 1970.

    Article  Google Scholar 

  31. Bracken RB, Sutow WW, Jaffe N, Ayala A, Guarda L: Preoperative chemotherapy for Wilms’ tumor. Urology 19: 55, 1982.

    Article  PubMed  CAS  Google Scholar 

  32. Kogan SJ, Marons H, Santorneau M, Schneider K, Reda E, Levitt SB: Successful treatment of renal vein and vena cavai extension of nephroblastoma by preoperative chemotherapy. J Urol 136: 312, 1986.

    PubMed  CAS  Google Scholar 

  33. Bray GL, Pendergrass TW, Schaller RT, Kiviat N, Beckwith JB: Preoperative chemotherapy in the treatment of Wilms’ tumor diagnosed with the aid of fine needle aspiration biopsy. Am J Pediatr Hematol Oncol 8: 75, 1986.

    Article  PubMed  CAS  Google Scholar 

  34. Lemerle J, Voute PA, Tournade MF: Effectiveness of preoperative chemotherapy in Wilms’ tumor: Results of an International Society of Pediatric Oncology (SIOP) clinical trial. J Clin Oncol 1: 640, 1983.

    Google Scholar 

  35. Zucker JM, Tournade MF, Voute PA, Delemarre JFM, deKraker J, Lemerle J Perry HJM, Rey A, Ducourtieux M, Com Nougue C: Report on SIOP-6 nephroblastoma trials. Proc of SIOP 31–34, 1986.

    Google Scholar 

  36. SIOP Nephroblastoma Trial, No. 9.

    Google Scholar 

  37. Beckwitn JB, Douglass EC, Rich M, Nisen P, Voute PA, Delemarre JFM, deKraker J, Ritchey ML, Kelalis PO, Arrigo S: Wilms’ tumor update: Current issues in management. Dialogues in Pediatric Urology, November, 1988.

    Google Scholar 

  38. Zuppan C, Beckwith B: Pretreated anaplastic Wilms’ tumor. Lab Invest 58: 108A, 1988.

    Google Scholar 

  39. Blute ML, Kelalis PP, Offord KP, Breslow N, Beckwith JB, D’Angio GJ: Bilateral Wilms’ tumor. J Urol 138: 968, 1987.

    PubMed  CAS  Google Scholar 

  40. Kelalis PP: Wilms’ tumor, [editorial] J Urol 135: 989, 1986.

    PubMed  CAS  Google Scholar 

  41. Weeks DA, Beckwith JB, Luckey DW: Relapse-associated variables in Stage 1 favorable histology Wilms’ tumor: A report of the National Wilms’ Tumor Study. Cancer 60: 1204, 1987.

    Article  PubMed  CAS  Google Scholar 

  42. Breslow NE, Churchill G, Nesmith B, Thomas PRM, Beckwith JB, Otherson HB, D’Angio GJ: Clinicopathologic features and prognosis for Wilms’ tumor patients with metastases at diagnosis. Cancer 58: 2501, 1986.

    Article  PubMed  CAS  Google Scholar 

  43. Thomas PRM, Shochat SJ, Norkook P, Breslow NE, D’Angio GJ: Prognostic implications of extension, invasion, or metastasis to the liver at diagnosis of Wilms’ tumor. Proc of ASCO 7: 255, 1988.

    Google Scholar 

  44. Maizels M, Wacksman J, Belman AB, Colodny AH: Management of Multicystic Dysplastic Kidney. Dialogues in Pediatric Urology, June, 1987.

    Google Scholar 

  45. Meredith Campbell Lecture. Nephrogenic rests, nephroblastomatosis, and Wilms’ Tumor, J. Bruce Beckwith, AUA 83rd Annual Meeting, Boston, MA June 3, 1988.

    Google Scholar 

  46. Thomas PRM, Griffith KD, Fineberg BB, Perez CA, Land VJ: Late effects of treatment for Wilms’ tumor. J Radiation Oncol Biol Phy 9: 651, 1983.

    Article  CAS  Google Scholar 

  47. D’Angio GJ: The child cured of cancer: A problem for the internist. Semin Oncol 9: 143, 1982.

    PubMed  Google Scholar 

  48. Jaffe N, McNeese M, Mayfield JK, Riseborough EJ: Childhood urologie cancer therapy related sequelae and their impact on management. Cancer 45: 1815, 1980.

    PubMed  CAS  Google Scholar 

  49. Ganick DJ: Wilms’ tumor. Hematology/Oncology Clinics North Am 1: 695, 1987.

    CAS  Google Scholar 

  50. Clausen N: Late recurrence of Wilms’ tumor. Med Pediatr Oncol 10: 557, 1982.

    Article  PubMed  CAS  Google Scholar 

  51. Johnson FL, Ballis FM: Hepatopathy following irradiation and chemotherapy for Wilms’ tumor. Am J Pediatr Hematol Oncol 4: 217, 1982.

    PubMed  Google Scholar 

  52. Barnard JA, Marshall GS, Neblett WW, Gray G, Grinshan FK: Noncirrhotic portal fibrosis after Wilms’ tumor therapy. Gastroenterology 90: 1054, 1986.

    PubMed  CAS  Google Scholar 

  53. Mitus A, Teftt M Fellers FX: Long-term follow-up of renal functions of 108 children who underwent nephrectomy for malignant disease. Pediatrics 44: 912, 1969.

    Google Scholar 

  54. O’Malley B, D’Angio GJ, Vawter GF: Effects of roentgen therapy given in infancy. Am J Roentgenol 89: 1067, 1963.

    Google Scholar 

  55. Wikstad I, Petterson BA, Elinder G, Sokucu S, Aperia A: A comperative study of size and function of the remnant kidney in patients nephrectomized in childhood for Wilms’ tumor and hydronephrosis. Acta Pediatr Scand 75: 408, 1986.

    Article  CAS  Google Scholar 

  56. Dinkel E, Britscho J, Dittrich, M, Schulte-Wissermann H, Ertel M: Renal growth in patients nephrectomized for Wilms’ tumor as compared to renal agenesis. Eur J Pediatr 147: 54, 1988.

    Article  PubMed  CAS  Google Scholar 

  57. Breslow NE, Norkool PA, Olshan A, Evans A, D’Angio GJ: Second malignant neoplasms in survivors of Wilms’ tumor: A report from the National Wilms’ Tumor Study. J Natl Cancer Inst 80: 592, 1988.

    Article  PubMed  CAS  Google Scholar 

  58. Mike V, Meadows AT, D’Angio GJ: Incidence of second malignant neoplasms in children: Results of an international study. Lancet 2: 1326, 1982.

    Article  PubMed  CAS  Google Scholar 

  59. Li FP, Yan JC, Sallan S: Second neoplasms after Wilms’ tumor in childhood. J Natl Cancer Inst 71: 1205, 1983.

    PubMed  CAS  Google Scholar 

  60. Tucker MA, Meadows AT, Boice JD: Cancer risk following treatment of childhood cancer. In: Radiation Carcinogenesis: Epidemiology and Biological Significance, Boice JD, Fraumeni JF Jr. (eds). Raven Press, New York, 1984, p. 211.

    Google Scholar 

  61. Li FP, Gimbrere K, Gelber RD, Sallan SE, Flamant F, Green DM, Heyn RM, Meadows AT: Outcome of pregnancy in survivors of Wilms’ tumor. JAMA 257: 216, 1987.

    Article  PubMed  CAS  Google Scholar 

  62. LI FP, Fine W, Jaffe N: Offspring of patients treated for cancer in childhood. J Natl Cancer Inst 62: 1193, 1979.

    PubMed  CAS  Google Scholar 

  63. Knudson AG Jr, Strong LC: Mutation and cancer: A model for Wilms’ tumor of the kidney. J Natl Cancer Inst 48: 313, 1972.

    PubMed  Google Scholar 

  64. Matsunaga E: Genetics of Wilms’ tumor. Hum Genet 57: 231, 1981.

    Article  PubMed  CAS  Google Scholar 

  65. Pendergrass TW: Congenital anomalies in chidren with Wilms’ tumor. A new survey. Cancer 37: 403, 1976.

    Article  PubMed  CAS  Google Scholar 

  66. Pastore G, Modesto C, Lemerle J, Tournade MF, Voute PA, Rey A, Vurgers JMV, Zucker JM, Gurger D, deKraker J, Delemarre JFM: Epidemiological features of Wilms’ tumor: Results of studies by the International Society of Paediatric Oncology (SIOP). Med Ped Oncol 16: 7, 1988.

    Article  CAS  Google Scholar 

  67. Ledlie EM, Mynors LS, Draper GJ, Gorbach PD: Natural history and treatment of Wilms’ tumor: An analysis of 335 cases occurring in England and Wales 1962–1966. Br Med J 4:195, 1970.

    Article  PubMed  CAS  Google Scholar 

  68. Breslow NE, Beckwith JB: Epidemiological features of Wilms’ tumor: Results of the National Wilms’ tumor Study. J Natl Cancer Inst 68: 429, 1982.

    PubMed  CAS  Google Scholar 

  69. Knudson AG, Jr: Genetics and the child cured of cancer. In: Status of the Curability of Childhood Cancer, van Eys J, Sullivan MP (eds). Raven Press, New York, 1980, p. 295.

    Google Scholar 

  70. Brodeur GM: Genetic and cytogenetic aspects of Wilms’ tumor. In: Wilms’ Tumor: Clinical and Biological Manifestations, Pochedly C, Baum ES (eds). Elsevier Science Publishing, New York, p. 125.

    Google Scholar 

  71. Miller RM, Fraumeni JF Jr, Manning MD: Association of Wilms’ tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270: 922, 1964.

    Article  PubMed  CAS  Google Scholar 

  72. DiGeorge AM, Harley RD: The association of aniridia, Wilms’ tumor, and genital abnormalities. Arch Opthalmol 75: 796, 1966.

    CAS  Google Scholar 

  73. Maurer HS, Pendergrass TW, Borges W, et al.: The role of genetic factors in the etiology of Wilms’ tumor. Cancer 43: 205, 1979.

    Article  PubMed  CAS  Google Scholar 

  74. Francke U, George DL, Brown MG, et al.: Gene dose effect: Intraband mapping of the LDH A locus using cells from four individuals with different interstitial deletions of lip. Cytogenet Cell Genet 19: 197, 1977.

    Article  PubMed  CAS  Google Scholar 

  75. Riccardi VM, Sujansky E, Smith AC, Francke U: Chromosomal imbalance in the aniridia Wilms’ tumor association: lip interstitial deletion. Pediatrics 61: 604, 1978.

    PubMed  CAS  Google Scholar 

  76. Riccardi VM, Hittner HM, Francke U, Yunis JJ, Ledbetter D, Borges W: The aniridia Wilms’ tumor association: The critical role of chromosome band llpl3. Cancer Genet Cytogenet 2: 131, 1980.

    Article  Google Scholar 

  77. Fearon ER, Vogelstein B, Feinberg AP: Somatic deletion and duplication of genes on chromosome 11 in Wilms’ tumours. Nature 309: 176, 1984.

    Article  PubMed  CAS  Google Scholar 

  78. Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, Cavenee WL: Loss of alleles at loci on human chromosome 11 during genesis of Wilms’ tumor. Nature 309: 170, 1984.

    Article  PubMed  CAS  Google Scholar 

  79. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK: Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 316: 330, 1985.

    Article  PubMed  CAS  Google Scholar 

  80. Riccardi VM, Hittner HM, Strong LC, et al.: Wilms’ tumor with aniridia/iris dysplasia and apparently normal chromosomes. J Pediatr 100: 574, 1982.

    Article  PubMed  CAS  Google Scholar 

  81. Weiacker P, Muller CR, Mayer A, et al.: Assignment of the gene coding for human catalase to the short arm of chromosome 11. Ann Genet 23: 73, 1980.

    Google Scholar 

  82. Junien L, Turleau C, deGrouchy J, et al.: Regional assignment of catalase (CAT) gene to band llpl3: Association with aniridia-Wilms’ tumor gonadoblastoma (WAGR) complex. Ann Genet 23: 165, 1980.

    PubMed  CAS  Google Scholar 

  83. Ferrell RE, Riccardi VM: Catalase levels in patients with aniridia and/or Wilms’ tumor: Utility and limitations. Cytogenet Cell Genet 31: 121, 1981.

    Article  Google Scholar 

  84. Harper ME, Ulrich A, Saunders GF: Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc Natl Acad Sci USa 78: 4458, 1981.

    Article  PubMed  CAS  Google Scholar 

  85. Compton DA, Weil MM, Jones C, Riccardi VM, Strong LC Saunders GF: Long range physical map of the Wilms’ tumor aniridia region on human chromosome 11. Cell 55: 827, 1988.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ellen Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Jewish Hospital of St. Louis, Washington University School of Medicine, 216 South Kingshighway Boulevard, St. Louis, Missouri, 63178, USA

    Herbert Lepor M.D.  & Timothy L. Ratliff Ph.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Shapiro, E. (1989). Recent advances and controversies in the management of Wilms’ tumor. In: Lepor, H., Ratliff, T.L. (eds) Urologic Oncology. Cancer Treatment and Research, vol 46. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1595-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1595-7_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8883-1

  • Online ISBN: 978-1-4613-1595-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation